News and Analysis | Published:

Cancer stem cell pipeline flounders

Nature Reviews Drug Discovery volume 17, pages 771773 (2018) | Download Citation

With clinical failures mounting and companies disinvesting, researchers are revising the cancer stem cell model.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

About this article

Publication history




  1. Search for Ken Garber in:

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing